Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink
Kawasaki Disease: Signs, Symptoms and Diagnosis | American Heart Association
Kawasaki Disease | KidsHealth NZ
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
How is Kawasaki's disease treated?
2021 ACR/VF Kawasaki Guidelines - Vasculitis Foundation
Treatment of Kawasaki disease | Download Table
Understanding Kawasaki Disease
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Kawasaki Disease Nursing Care Management: Study Guide
An Overview of Kawasaki Disease
Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials - eBioMedicine
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Kawasaki Disease in Infants & Young Children - HealthyChildren.org
Clinical Practice Guidelines : Kawasaki disease
Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease - ScienceDirect